相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
Raul D. Santos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
New Pharmacological Approaches to Target PCSK9
Alberico L. Catapano et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2020)
Autocrine effects of PCSK9 on cardiomyocytes
Annemarie Wolf et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
Lorenzo Da Dalt et al.
EUROPEAN HEART JOURNAL (2019)
Cholesterol metabolism, pancreatic β-cell function and diabetes
Carla Perego et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Novel strategies to target proprotein convertase subtilisin kexin 9: beyond monoclonal antibodies
Nabil G. Seidah et al.
CARDIOVASCULAR RESEARCH (2019)
Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies
Helena C. Kenny et al.
CIRCULATION RESEARCH (2019)
PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2018)
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
Andrea Baragetti et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
Giuseppe Danilo Norata et al.
CARDIOVASCULAR RESEARCH (2016)
Lipid Use and Misuse by the Heart
P. Christian Schulze et al.
CIRCULATION RESEARCH (2016)
Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes A Meta-analysis
Luca A. Lotta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A. Ference et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver
Annie Demers et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
Alessandra Dei Cas et al.
JACC-HEART FAILURE (2015)
PCSK9: A Key Modulator of Cardiovascular Health
Nabil G. Seidah et al.
CIRCULATION RESEARCH (2014)
Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management
Martin A. Alpert et al.
TRANSLATIONAL RESEARCH (2014)
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production
Torsten Doenst et al.
CIRCULATION RESEARCH (2013)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)
Maryssa Canuel et al.
PLOS ONE (2013)
Lipid Metabolism and Toxicity in the Heart
Ira J. Goldberg et al.
CELL METABOLISM (2012)
Hypertension and Heart Failure The ALLHAT Imperative
Richard J. Rodeheffer
CIRCULATION (2011)
The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction
Jeanna C. Perman et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Guenter Haemmerle et al.
NATURE MEDICINE (2011)
Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways IN VIVO EVIDENCE FOR RECEPTOR- AND NON-RECEPTOR-MEDIATED FATTY ACID UPTAKE
Kalyani G. Bharadwaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
Ni-Huiping Son et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Myocardial fatty acid metabolism and cardiac performance in heart failure
Helena Tuunanen et al.
Current Cardiology Reports (2008)
The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2
Steve Poirier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease
T Pulinilkunnil et al.
CARDIOVASCULAR RESEARCH (2006)
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
S Sharma et al.
FASEB JOURNAL (2004)
Cardiac fatty acid uptake and transport in health and disease
GJ van der Vusse et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
